Welcome to the e-CCO Library Archive!

Filter:
P210. Azathioprine versus azathioprine plus metronidazole for the prevention of postoperative endoscopic recurrence of Crohn's disease: A randomized, placebo-controlled trial
P210. Intestinal mucosal calprotectin (iMC) in ulcerative colitis (UC): measuring disease activity, defining remission and predicting outcome
Authors:

M. Guirgis1, E. Wendt1, L.M. Wang2, P. Basset3, D. Burger1, A. Kent1, R. Adamson1, S. Travis1, S. Keshav1, 1Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, United Kingdom, 2Department of Cellular Pathology, John Radcliffe Hospital, Oxford, United Kingdom, 3StatsConsultancy Limited, United Kingdom

P210

Calprotectin predicts relapse of IBD even in the presence of a 'normal' colonoscopy

Authors:

R. Deberry, A. Rahman, P. Dubois, G. Chung-Faye, B. Hayee*

King's College Hospital NHS Foundation Trust, Gastroenterology, London, United Kingdom

P211.

IBD-Unclassified in childhood and adolescence; a complicated diagnosis

Authors:

D.A. Winter1, J.C. Escher1, E. Porto2, IBD Working Group of ESPGHAN, 1Erasmus MC-Sophia Children's Hospital, Pediatric Gastroenterology, Rotterdam, Netherlands, 2European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Porto, Portugal

P211. Interaction between pregnancy and inflammatory bowel disease in a Portuguese series of patients
Authors:

D. Trabulo1, C. Martins1, S. Ribeiro1, C. Cardoso1, J. Mangualde1, I. Cremers1, A.P. Oliveira1, 1Centro Hospitalar de Setúbal – Hospital de São Bernardo, Gastroenterology, Setúbal, Portugal

P211. Role of perception direction in patients with inflammatory bowel diseases and irritable bowel syndrome
P211. The presence of microscopic disease at the resection margins predicts post-surgical relapse in Crohn's disease
P211

Gender-related differences in work productivity impairment and quality of life in Inflammatory Bowel Disease (IBD): A cross-sectional survey from Southern Italy

Authors:

M. Cappello*, R. Alloro, M. Mazza, M. Mendolaro, P.L. Almasio, A. Craxì

University of Palermo, Gastroenterology Section, DiBiMis, Palermo, Italy

P212.

How to ameliorate histology accuracy in IBD diagnosis: role for a better interaction between clinicians and pathologists?

Authors:

M. Daperno1,2, G. Canavese3, R. Suriani1, A. Sapino3, R. Rocca1,2, V. Villanacci4, O. Onlus1, on behalf of Fondazione IBD, 1Fondazione IBD Onlus, IBD Foundation, Torino, Italy, 2AO Ordine Mauriziano, Gastroenterology Division, Turin, Italy, 3AO S. Giovanni Battista – Città della Salute, Pathology Department, Torino, Italy, 4Spedali Civili di Brescia, Pathology Depratment, Brescia, Italy

P212. Clinical outcomes in patients with moderate versus severe Crohn's disease at baseline: Analysis from CARE
P212. Inter- and intra-observer variation in histologic diagnosis of microscopic colitis and subgroups
Authors:

A.-M.K. Fiehn1, C. Bjørnbak2, M. Warnecke3, P.J.H. Engel1, L.K. Munck2, 1Roskilde Sygehus, Dept. of Pathology, Roskilde, Denmark, 2Køge sygehus, Dept. of Int. Med., Køge, Denmark, 3Slagelse Sygehus, Dept. of Pathology, Slagelse, Denmark

P212. Pharmacokinetics of iron isomaltoside 1000 in inflammatory bowel disease (IBD)
P212

Serum biomarkers predict disease severity in Ulcerative Colitis

Authors:

C. Soendergaard*1, O.H. Nielsen1, J.B. Seidelin1, P.H. Kvist2, J.T. Bjerrum1

1Herlev University Hospital, Department of Gastroenterology, Copenhagen, Denmark, 2Novo Nordisk A/S, Histology, Maaloev, Denmark

P213.

High prevalence of subclinical ultrasonographic synovitis in patients with inflammatory bowel disease

Authors:

E. Vicente1, S. Pérez2, M. Chaparro3, F. Rodríguez-Salvanés4, S. Castañeda1, J.P. Gisbert3, 1Hospital La Princesa, IIS-P, Rheumatology Department, Madrid, Spain, 2Fundación Jiménez Díaz, Rheumatology Department, Madrid, Spain, 3Hospital Universitario de La Princesa, IP and CIBERehd, Gastroenterology Unit, Madrid, Spain, 4Hospital La Princesa, IIS-P, Epidemiologic Research Unit, Madrid, Spain

P213. Benefit–risk assessment of adalimumab as maintenance treatment for ulcerative colitis: Near analysis of week 8 responders in ULTRA 2
P213. Influence of clinical history on scoring of the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)
Authors:

S.P. Travis1, D. Schnell2, P. Krzeski3, J.-F. Colombel4, B.G. Feagan5, W. Reinisch6, B.E. Sands7, B.R. Yacyshyn8, C.A. Bernhardt9, J.-Y. Mary10, W.J. Sandborn11, 1Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, United Kingdom, 2Middletown, United States, 3Warner Chilcott, Weybridge, United Kingdom, 4Hôpital Claude Huriez, Centre Hospitalier Universitaire de Lille, Lille, France, 5University of Western Ontario, Robarts Clinical Trials, Robarts Research Institute, Ontario, Canada, 6Universitatsklinik Innere Medizin III, Abteilung Gastroenterologie und Hepatologie, Medical University of Vienna, Vienna, Austria, 7Mount Sinai Hospital, New York, United States, 8University of Cincinnati, Division of Digestive Diseases, Cincinnati, Ohio, United States, 9Bernhardt Regulatory Consulting, Cincinnati, Ohio, United States, 10INSERM U717 Biostatistics and Clinical Epidemiology, Universite Paris Diderot, Paris, France, 11Division of Gastroenterology, University of California San Diego, La Jolla, California, United States

P213. Use of azathioprine during pregnancy and in the postoperative setting in Crohn's disease: A worldwide survey of experts
P213

A systematic review and meta-analysis of non-invasive biomarkers for assessing disease activity in Inflammatory Bowel Disease

Authors:

M.H. Mosli*1, 2, G. Zou1, 3, S.K. Garg4, S.G. Feagan1, J.K. MacDonald1, W.J. Sandborn1, 5, N. Chande6, B.G. Feagan1, 3, 7

1Robarts Clinical Trials Inc., Robarts Research Institute, University of Western Ontario, London, Ontario, Canada, 2King Abdulaziz University, Department of Medicine, Jeddah, Saudi Arabia, 3University of Western Ontario, Department of Epidemiology and Biostatistics, London Ontario, Canada, 4University of Minnesota, Department of Medicine, Minneapolis, United States, 5University of California San Diego, Division of Gastroenterology, La Jolla, United States, 6London Health Sciences Centre, Victoria Hospital, London, Canada, 7University of Western Ontario, Department of Medicine, London , Canada

P214.

Health-related quality of life among patients with primary sclerosing cholangitis

Authors:

J. Haapamäki1, H. Sintonen2, N. Barner-Rasmussen1, M. Färkkilä1, 1Helsinki University Central Hospital, Division of Gastroenterology, Helsinki, Finland, 2University of Helsinki, Department of Public Health, Hjelt Institute, Helsinki, Finland

P214. Faecal calprotectin assay after induction with anti-TNF alpha agents in IBD patients: prediction of clinical response and mucosal healing at one year
Authors:

L. Guidi1, M. Marzo1, G. Andrisani1, C. Felice1, D. Pugliese1, I. De Vitis1, A. Papa1, G.L. Rapaccini1, F. Forni2, A. Armuzzi1, 1Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy, 2Clinical Laboratory Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy